Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
MKRN3 inhibits the reproductive axis through actions in kisspeptin-expressing neurons
Ana Paula Abreu, … , Sergio Ojeda, Ursula B. Kaiser
Ana Paula Abreu, … , Sergio Ojeda, Ursula B. Kaiser
Published May 14, 2020
Citation Information: J Clin Invest. 2020;130(8):4486-4500. https://doi.org/10.1172/JCI136564.
View: Text | PDF
Research Article Endocrinology

MKRN3 inhibits the reproductive axis through actions in kisspeptin-expressing neurons

  • Text
  • PDF
Abstract

The identification of loss-of-function mutations in MKRN3 in patients with central precocious puberty in association with the decrease in MKRN3 expression in the medial basal hypothalamus of mice before the initiation of reproductive maturation suggests that MKRN3 is acting as a brake on gonadotropin-releasing hormone (GnRH) secretion during childhood. In the current study, we investigated the mechanism by which MKRN3 prevents premature manifestation of the pubertal process. We showed that, as in mice, MKRN3 expression is high in the hypothalamus of rats and nonhuman primates early in life, decreases as puberty approaches, and is independent of sex steroid hormones. We demonstrated that Mkrn3 is expressed in Kiss1 neurons of the mouse hypothalamic arcuate nucleus and that MKRN3 repressed promoter activity of human KISS1 and TAC3, 2 key stimulators of GnRH secretion. We further showed that MKRN3 has ubiquitinase activity, that this activity is reduced by MKRN3 mutations affecting the RING finger domain, and that these mutations compromised the ability of MKRN3 to repress KISS1 and TAC3 promoter activity. These results indicate that MKRN3 acts to prevent puberty initiation, at least in part, by repressing KISS1 and TAC3 transcription and that this action may involve an MKRN3-directed ubiquitination-mediated mechanism.

Authors

Ana Paula Abreu, Carlos A. Toro, Yong Bhum Song, Victor M. Navarro, Martha A. Bosch, Aysegul Eren, Joy N. Liang, Rona S. Carroll, Ana Claudia Latronico, Oline K. Rønnekleiv, Carlos F. Aylwin, Alejandro Lomniczi, Sergio Ojeda, Ursula B. Kaiser

×

Figure 8

MKRN3 undergoes auto-ubiquitination and MKRN3 mutants are less ubiquitinated than WT MKRN3.

Options: View larger image (or click on image) Download as PowerPoint
MKRN3 undergoes auto-ubiquitination and MKRN3 mutants are less ubiquitin...
(A) HEK293T cells were transfected with a plasmid encoding WT MKRN3 (WT), or were untransfected (UT). The membrane was immunoblotted with anti-MKRN3, and with anti–β-actin as control. Whole-cell lysates revealed a smear, typical of the pattern shown by polyubiquitinated proteins. Coexpression of his-ubiquitin with MKRN3 resulted in a smear of larger complexes, corresponding to polyubiquitinated protein. (B and C) HEK293T cells were transfected with empty pcDNA, WT MKRN3, or mutant MKRN3. Immune complexes were precipitated using protein A anti-HA beads and probed with anti-ubiquitin (upper panel) or anti-HA (middle panel); lower panels correspond to whole-cell lysates probed with anti-HA. (B) Transfected cells treated with vehicle. Upper panel: An upper smear is present when immunoblotted with anti-ubiquitin; it is stronger in the lane loaded with protein from cells transfected with WT MKRN3 than with MKRN3 mutants. Middle panel: Immunoblotting with anti-HA shows a main band below 75 kDa in lanes with WT MKRN3 and MKRN3 mutants, likely corresponding to a mature form of MKRN3; a band at 50 kDa was also detected in lysates from both WT and mutant MRKN3, but was significantly weaker in intensity for C340G MKRN3 compared with WT MKRN3 and other mutants. (C) Transfected cells treated with MG132. Upper panel: Probing with anti-ubiquitin results in a smear suggestive of auto-ubiquitination that is stronger with WT MKRN3 compared with the MKRN3 mutants located in the zinc finger, F417I and H420G, and is weakest for the RING finger mutants, C340G and R365S. Middle panel: Probed with anti-HA, protein levels are similar for WT MKRN3 and all mutants. In all, anti–β-actin antibody (bottom panels) was a loading control. WT, WT MKRN3; UT, untransfected cells; MW, molecular weight.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts